J Dent Res:窝沟龋的治疗

2015-03-16 MedSci MedSci原创

J Dent Res:窝沟龋的治疗关键词:牙釉质 牙本质 氟化物 牙体修复失败对于浅或中等深度的窝沟龋可有不同的治疗方案:(1)无创治疗,如氟化物的应用、抗菌治疗和口腔卫生保健等,避免了牙体组织的磨除;(2)微创治疗,如窝沟封闭,通过酸蚀仅去除少量的牙体硬组织;最小程度的有创治疗,如“预防性”树脂/密封胶充填,去除龋坏的牙体组织以避免龋坏累及整个牙齿。本研究的目的是使用meta分析,系统性的回顾并


对于浅或中等深度的窝沟龋可有不同的治疗方案:(1)无创治疗,如氟化物的应用、抗菌治疗和口腔卫生保健等,避免了牙体组织的磨除;(2)微创治疗,如窝沟封闭,通过酸蚀仅去除少量的牙体硬组织;最小程度的有创治疗,如“预防性”树脂/密封胶充填,去除龋坏的牙体组织以避免龋坏累及整个牙齿。

本研究的目的是使用meta分析,系统性的回顾并对比了恒牙窝沟龋的治疗方法。采用随机或非随机临床试验调查研究窝沟裂表面浅或中等深度的龋坏病损。研究人员对比了有创性治疗与其它无创性治疗、微创性治疗和最小程度有创性治疗后继发龋发生的危险性;未处理龋坏牙齿作为对照。系统性的筛选了截止至2013年9月的五个电子数据库的文章,Pairwise及网状meta分析了所有文章,计算了比值比和95%可信区间。采用GRADE进行估计。共搜索了2214篇文献,有14项研究,涉及1440名患者3551个龋坏病损。

Pairwise meta分析发现,与对照组相比,微创和最小程度有创治疗龋坏病损侵入牙体组织的量较小(比值比和【95%的可信区间】分别为:0.13【0.07到0.26】,0.13【0.03到0.05】),然而评估的非侵入性治疗病损则无明显差别(比值比和95%可信区间:0.64【039到1.06】)。

网络荟萃分析表明继发龋发生的危险性从小到大为:首先是最小程度有创治疗,其次是微创治疗,再次是无创治疗。然而,相对于最小程度治疗和无创治疗,微创治疗包括了所有的治疗(包括窝沟封闭)。由于本研究的局限性,证据缺乏足够的说服力,因此,临床治疗时,需要考虑牙齿远期效果,不同治疗方法的费用以及患者的主观意愿。

原始出处:

Schwendicke F, Jäger AM, Paris S, Hsu LY, Tu YK. Treating Pit-and-Fissure Caries
A Systematic Review and Network Meta-analysis.
J Dent Res. 2015 Feb 20. pii: 0022034515571184.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=125379, encodeId=9f001253e9a4, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:32:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45512, encodeId=8d0945512bc, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151119/IMG564D22F85A3BB6344.jpg, createdBy=750e1664472, createdName=De_dzw, createdTime=Fri Dec 11 00:01:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19077, encodeId=ceaa190e7fc, content=治疗方案的制定, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Mon Mar 30 16:45:00 CST 2015, time=2015-03-30, status=1, ipAttribution=)]
    2016-09-13 1e10c84am36(暂无匿称)

    好文章,还会关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=125379, encodeId=9f001253e9a4, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:32:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45512, encodeId=8d0945512bc, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151119/IMG564D22F85A3BB6344.jpg, createdBy=750e1664472, createdName=De_dzw, createdTime=Fri Dec 11 00:01:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19077, encodeId=ceaa190e7fc, content=治疗方案的制定, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Mon Mar 30 16:45:00 CST 2015, time=2015-03-30, status=1, ipAttribution=)]
    2015-12-11 De_dzw

    很有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=125379, encodeId=9f001253e9a4, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:32:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45512, encodeId=8d0945512bc, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151119/IMG564D22F85A3BB6344.jpg, createdBy=750e1664472, createdName=De_dzw, createdTime=Fri Dec 11 00:01:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=19077, encodeId=ceaa190e7fc, content=治疗方案的制定, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Mon Mar 30 16:45:00 CST 2015, time=2015-03-30, status=1, ipAttribution=)]
    2015-03-30 ixiaochengdudu

    治疗方案的制定

    0